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The combined application of linear amplification-mediated PCR (LAM-PCR) protocols 
with next-generation sequencing (NGS) has had a large impact on our understanding of 
retroviral pathogenesis. Previously, considerable effort has been expended to optimize 
NGS methods to explore the genome-wide distribution of proviral integration sites and 
the clonal architecture of clinically important retroviruses like human T-cell leukemia virus 
type-1 (HTLV-1). Once sequencing data are generated, the application of rigorous 
bioinformatics analysis is central to the biological interpretation of the data. To better 
exploit the potential information available through these methods, we developed an 
optimized bioinformatics pipeline to analyze NGS clonality datasets. We found that short-
read aligners, specifically designed to manage NGS datasets, provide increased speed, 
significantly reducing processing time and decreasing the computational burden. This is 
achieved while also accounting for sequencing base quality. We demonstrate the utility 
of an additional trimming step in the workflow, which adjusts for the number of reads 
supporting each insertion site. In addition, we developed a recall procedure to reduce 
bias associated with proviral integration within low complexity regions of the genome, 
providing a more accurate estimation of clone abundance. Finally, we recommend the 
application of a “clean-and-recover” step to clonality datasets generated from large cohorts 
and longitudinal studies. In summary, we report an optimized bioinformatics workflow for 
NGS clonality analysis and describe a new set of steps to guide the computational process. 
We demonstrate that the application of this protocol to the analysis of HTLV-1 and bovine 
leukemia virus (BLV) clonality datasets improves the quality of data processing and provides 
a more accurate definition of the clonal landscape in infected individuals. The optimized 
workflow and analysis recommendations can be  implemented in the majority of 
bioinformatics pipelines developed to analyze LAM-PCR-based NGS clonality datasets.
Keywords: human T-cell leukemia virus type-1, bovine leukemia virus, linear amplification-mediated-PCR, adult 
T-cell leukemia, retrovirus, clonal architecture, bioinformatics pipeline, integration site
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INTRODUCTION
A hallmark of all retroviral infections and an essential step 
in the life cycle is the proviral DNA integration into the host 
genome (Demeulemeester et  al., 2015). More than a lifelong 
signature, the clonal distribution of proviral integration sites 
(IS) significantly influences the fate of infected cells (Cohn 
et  al., 2015; Rosewick et  al., 2017). Recently, the application 
of linear amplification-mediated PCR (Schmidt et  al., 2002, 
2007; LAM-PCR) and next-generation sequencing (NGS) has 
facilitated the identification of hundreds of thousands of retroviral 
integration sites genome-wide while simultaneously measuring 
the abundance of the corresponding clones (Paruzynski et  al., 
2010; Gillet et  al., 2011; Firouzi et  al., 2014; Maldarelli et  al., 
2014; Wagner et  al., 2014; Sunshine et  al., 2016; Artesi et  al., 
2017; Rosewick et  al., 2017). Analyses by us and others have 
demonstrated that the integration sites of human T-cell leukemia 
virus type-1 (HTLV-1; Gillet et al., 2011; Melamed et al., 2013; 
Cook et  al., 2014; Rosewick et  al., 2017), bovine leukemia 
virus (BLV; Gillet et  al., 2013; Rosewick et  al., 2017), avian 
leukemia virus (ALV; Justice et al., 2015; Malhotra et al., 2017), 
and human immunodeficiency virus-1 (HIV-1; Maldarelli et al., 
2014; Wagner et  al., 2014; Cohn et  al., 2015; Einkauf et  al., 
2019) are not random and, in the case of BLV/HTLV-1, revealed 
hotspots of proviral integration sites in the vicinity of cancer 
driver genes (Rosewick et  al., 2017). The application of NGS 
clonality approaches to HIV-1 seropositive patients treated with 
combination antiretroviral therapy (cART) uncovered viral 
reservoirs of latently infected cells responsible for rapid viral 
rebound if the therapy is interrupted (Finzi et al., 1999; Maldarelli 
et  al., 2014). Analysis of HIV-1 clonality also revealed subsets 
of clonally expanded cells often containing defective proviruses, 
although intact infectious HIV-1 has also been reported in 
highly expanded clones (Cohn et  al., 2015; Simonetti et  al., 
2016). In addition to natural retroviral infections by exogenous 
and endogenous retroviruses, transduction strategies utilizing 
retroviral vectors have been developed and widely used for 
gene therapy applications (Cavazzana-Calvo et al., 2000). Potential 
adverse effects resulting from insertional mutagenesis caused 
by retro‐ and lentiviral vector-mediated transduction of target 
cells can be tracked by NGS-based mapping of vector integration 
sites (De Ravin et al., 2016). Systematic exploration of insertion 
sites is currently recommended by the FDA as an approach to 
assess the risk of integration-related effects in gene therapy clinical 
trials (FDA Center for Biologics Evaluation and Research, 2019).
While NGS techniques based on capture probes have 
generated a genome-wide picture of HTLV-1 and HIV-1 
integration sites and their associated proviral genomes (Iwase 
et al., 2019; Katsuya et al., 2019), capture-dependent approaches 
are limited in their throughput and are not well suited to 
exploring early nonmalignant stages of infection where only 
a small fraction of the cells carries the integrated provirus. 
We  and others have used more high-throughput NGS 
integration site profiling approaches consisting of LAM-PCR 
followed by NGS (Paruzynski et  al., 2010; Gillet et  al., 2011; 
Firouzi et  al., 2014; Sunshine et  al., 2016; Percher et  al., 
2017; Rosewick et  al., 2017). These methods share a first 
step of DNA fragmentation by restriction enzyme digestion 
or ultrasonic shearing of the genomic DNA followed by 
viral long terminal repeat (LTR)-specific amplification of 
the adjacent genomic sequences. The amplification product 
spans the virus–host junction, revealing the integration site. 
Libraries are produced by PCR amplification of adapter-
ligated products. Three NGS methods have been developed 
to specifically explore the clonal architecture of virus-infected 
cells in HTLV-1‐ and BLV-infected individuals (Gillet et  al., 
2011; Firouzi et  al., 2014; Rosewick et  al., 2017). In the 
method described by Gillet (2011), sheared DNA fragments 
are end-repaired and tailed with a 3' A-overhang before 
ligating a Y-shaped adapter. Fragments are PCR amplified 
with primers located in the 3' LTR and the adapter region. 
Combined information regarding the integration site and 
the shear site defines clone abundance. Work by Firouzi 
and colleagues (Firouzi et al., 2014) improved the estimation 
of clonal abundance by the introduction of unique molecular 
identifiers (UMI). Amplification is performed by nested-
splinkerette PCR, targeting the 3' LTR (Potter and Luo, 
2010). In the method developed in our laboratory (Rosewick 
et  al., 2017; Figure  1), the sheared DNA fragments are 
selectively end repaired and A tailed via Taq polymerase 
extension from LTR-specific primers that extend into the 
host DNA from both the 5' and 3' LTRs. Biotinylated dTTPs 
are also incorporated during this extension step. Y-shaped 
adapters containing UMIs are ligated to the A overhangs, 
and streptavidin bead-mediated selection is carried out, 
followed by PCR amplification. Removal of PCR duplicates 
combining UMI, shear site, and integration site information 
ensures accurate estimation of clone abundance. Overall, 
our approach comprises several modifications compared to 
the previously reported protocols. The modified method 
assesses both the 5' and 3' LTR flanking sequences, increases 
the sensitivity, and significantly reduces the cost, making it 
a viable technique for application in the clinic. In a longitudinal 
study of adult T-cell leukemia (ATL) patients, we demonstrated 
that the optimized NGS mapping protocol applied to HTLV-1 
outperformed other currently available methods, enabling 
the detection of patients refractory to first-line therapy and 
providing a better estimation of response to therapy (Artesi 
et  al., 2017). We  have then applied this method to samples 
collected from HTLV-1‐ and BLV-infected individuals of 
human, ovine, and bovine origin as well as HTLV-1 infected 
humanized mice, reflecting both basic and clinical settings 
(Artesi et  al., 2017; Percher et  al., 2017; Rosewick et  al., 
2017; Pérès et  al., 2018; Galli et  al., 2019; Marçais et  al., 
2020). This generated an unprecedented volume of raw 
sequencing data. Here, we report the bioinformatics workflow 
and describe critical modifications in the pipeline, improving 
Abbreviations: LAM-PCR, Linear amplification-mediated PCR; NGS, Next-
generation sequencing; IS, Integration site; HTLV-1, Human T-cell leukemia 
virus-1; BLV, Bovine leukemia virus; ALV, Avian leukemia virus; HIV-1, Human 
immunodeficiency virus-1; cART, Combination antiretroviral therapy; LTR, Long 
terminal repeat; UMI, Unique molecular identifier; ATL, Adult T-cell leukemia; 
MAPQ, Mapping quality score.
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processing speed, increasing both the specificity and the 
sensitivity of the assay, and reducing bias associated with 
proviral integration within low complexity regions of the 
genome. We  provide an updated data analysis protocol and 
recommendations applicable to the majority of bioinformatics 




NGS clonality datasets were obtained from peripheral blood 
mononuclear cells collected from ATL patients (HTLV-1, human 
dataset) and BLV-infected animals (asymptomatic and tumor 
stages) described in Artesi et al. (2017) and Rosewick et al. (2017). 
The human studies were approved by the ethics committee CPP 
Ile de France II, CNIL: number 1692254 and registration number 
000001072. Animal experimental procedures were approved by 
the University of Saskatchewan Animal Care Committee, following 
the Canada Council on Animal Care Guidelines.
Library Preparation and Sequencing
Clonality libraries were prepared according to Rosewick et al. (2017) 
and Artesi et  al. (2017; Figure  1B). Briefly, DNA is sheared, 
and fragments of 300–700  bp are selectively end repaired and 
A tailed with biotinylated dTTPs and LTR-specific primers. 
Fragments containing LTR–host junctions with ligated adaptors 
providing a random tag (for PCR duplicate identification) 
and a linker (multiple linkers are used to identify cross-
contamination) are then captured with streptavidin beads. 
DNA fragments are PCR amplified, and after purification of 
A
B
FIGURE 1 | NGS clonality assays to explore the clonal landscape of infected cells. (A) Integration site distribution and clonal landscape in human T-cell leukemia 
virus type-1 (HTLV-1) and bovine leukemia virus (BLV)-associated malignancies. HTLV-1 and BLV infect T cells and B cells respectively, producing a chronic infection 
in their respective hosts (human and cattle/sheep) that evolves into full-blown leukemia/lymphoma in ~5% of individuals. Infected cells carry the viral genetic material 
or “proviral” DNA stably integrated into their genome. Early and chronic stages of infection are characterized by a large number of clones of low abundance, each 
uniquely identified by their proviral integration site in the genome. In each individual, the virus persists in several thousand distinct infected cell clones. Following a 
protracted latency period, for unknown reasons, one of these clones dramatically expands, leading to the accumulation of malignant cells in the blood (leukemia) or 
peripheral tissues (lymphoma). Exploring the clonal landscape over time is critical in understanding tumor evolution. Next-generation sequencing (NGS) clonality 
assays have the capacity to identify proviral integration sites genome-wide and simultaneously measure the abundance of the corresponding clones. (B) NGS library 
preparation. DNA is sheared by ultrasonication and fragments of 300–700 bp are further processed by linear extension with biotinylated dTTPs and long terminal 
repeat (LTR)-specific primers (5'‐ and 3'-specific). A ligation step adds an adapter, providing a random tag, a linker, and Nextera forward sequences to the fragments 
containing LTR-host junctions. After capture with streptavidin beads, DNA fragments are PCR amplified, which adds the Nextera reverse sequences and a stretch of 
random nucleotides to produce sequence complexity. The products are then amplified using off-the-shelf Nextera indexes to enable multiplexing. Libraries are 
sequenced on a MiSeq instrument (kit V2, 2 × 150 bp).
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the products, a second PCR is performed, which adds off-the-
shelf Nextera indexes. Libraries are sequenced on a MiSeq 
instrument (kit V2, 2  ×  150  bp).
Proviral Integration Site Calling
A detailed step-by-step description of the proviral integration 
site calling pipeline is available on github: https://github.com/
GIGA-AnimalGenomics-BLV/Public/tree/master/PIC.
Testing Blast Versus Bowtie2
Bowtie2 v2.2.9 index (bowtie2-build) and BLAST v2.6 
(makeblastdb-dbtype nucl) databases were constructed from 
the BLV_YR2 3'LTR (8,694–8,720  bp, BLV YR2, Genbank: 
KT122858.1) or HTLV_ATK (9011–9,055 bp, GenBank: J02029) 
sequence. Ten million reads containing either the BLV or 
HTLV-1 3'LTR sequence were randomly selected from our NGS 
clonality sequencing dataset. Datasets were downsampled to 
different sets of various read numbers with seqtk.1 FASTQ 
files were transformed into FASTA with fastq_to_fasta (-Q33 -r -n) 
keeping only bases with Phred score  >  33.2 FASTA sequences 
were compared to the BLAST database using blastn -word_size 
7 -evalue 1. FASTQ sequences were aligned with bowtie2 
(-L 14 -N 1 -U). Homemade R scripts were used to compare 
the outputs.
Impact of Read Trimming on Proviral 
Integration Site Mapping
Bowtie2 indexes were constructed with BLV LTRs or HTLV-1 
LTRs as separate chromosomes (BLV, LTR5: 1–30  bp, LTR3: 
8,694–8,720 bp; HTLV, LTR5: 1–29 bp, LTR3: 9,011–9,055 bp). 
Reads from BLV-infected sheep (n  =  516) or HTLV-1-infected 
individuals (n = 187) containing the appropriate linker sequence 
were mapped to their respective index with bowtie2 -L 14 -N 
1 -U prior to or after trimming. Trimming was performed in 
two steps. First, the read section expected to contain the viral 
LTR was isolated with fastx_trimmer. Next, cutadapt -n 2 -m 
10 was used to remove residual sequences, which arise from 
read overlap (see github for details). Custom R scripts were 
used to compare the outputs.
Integration Site Recall
A recall procedure was performed using custom R scripts 
[available in the github R package PIC function getISposition 
(…, RECALL  =  TRUE)]. Trimmed reads from 184 HTLV-1 
infected samples with at least 300 reads after removal of PCR 
duplicates were mapped with bowtie2 -very-sensitive -N 1 to 
the combined human genome (hg19) with the HTLV-1 proviral 
genome as an additional chromosome (HTLV_ATK, GenBank: 
J02029). Using the R package PIC, the position and abundance 
of integration sites were first called with high-confidence reads 
mapped in proper pairs (SAM flags 83, 99, 147, 163, and 
MAPQ ≥ 33). For each integration site, the RECALL abundance 
1 https://github.com/lh3/seqtk
2 http://hannonlab.cshl.edu/fastx_toolkit/
was calculated from the set of reads located in a window 
spanning 600  bp up‐ and downstream of the high-confidence 
integration site. Multi-mapped reads attributed to two distinct 
integration sites were assigned using clone abundance as weight 
factor. Like with high-confidence reads, PCR duplicates were 
removed based on the integration site, shear site, and random 
tag information.
Clean and Recover Step
Integration sites (704,485) were acquired from longitudinal samples 
collected from 30 BLV-infected sheep over >5  years (n  =  553, 
unpublished data). From this dataset 377,710 unique integration 
sites were obtained. Integration sites found in only one animal 
were retained, while those detected in >1 animal were further 
explored. Their relative distribution across all serial samples of 
each individual was assessed by computing the Shannon entropy 
(Shannon, 1948) of their recurrence (= number of times this 
integration site is detected in each animal; Sr) and highest 
abundance across all animals and all samples (Sa). Integration 
sites with a Sr or Sa <0.85 were attributed to the animal with 
the highest recurrence (if Sr <0.85) or the highest abundance 
(if Sa <0.85) of that particular integration site. Integration sites 
that did not meet any of these criteria were flagged as “uncertain” 
and excluded, while the others were retrieved. This category 
contains integration sites found at a similar occurrence in different 
animals and at a low abundance in each of them. A detailed 
description of the protocol is available on github https://github.
com/GIGA-AnimalGenomics-BLV/Public/tree/master/PIC/R. The 
corresponding function is called tagContamination().
Availability of Data and Materials
Integration site information and NGS clonality datasets are 
available from previous publications (Artesi et al., 2017; Rosewick 
et al., 2017). The datasets used and analyzed during the current 
study are also available from the corresponding author on 
request. The full code and a detailed step-by-step description 




Libraries were prepared according to Rosewick et  al. (2017) 
and Artesi et al. (2017), and sequenced on an Illumina MiSeq 
instrument with 2 × 150-bp reads (see Materials and Methods 
section). Read 1 (R1) consists of three elements. First a stretch 
of six random nucleotides (complexity sequence), which provide 
higher sequence diversity at the 5' read extremity and improve 
sequencing quality on the Illumina platform. Second, a proviral 
LTR sequence consisting of the primer sequence used for 
linear amplification followed by the downstream LTR extremity 
(LTR). Third, the flanking host genomic sequence corresponding 
to the integration site. Read 2 (R2) contains an 8-bp random 
tag ligated prior to PCR amplification, a 14-bp linker sequence 
unique to each library to avoid cross-contamination between 
Rosewick et al. Improved Bioinformatics Pipeline NGS Clonality
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libraries, followed by the host genomic sequence defining 
the random shear site generated by sonication. We  designed 
a six-step workflow to analyze the NGS datasets (Figure  2). 
The full code of the bioinformatics pipeline is available at 
https://github.com/GIGA-AnimalGenomics-BLV/Public/tree/
master/PIC.
Accelerating Data Processing: Favoring 
Short-Read Aligners Over BLAST/BLAT
Reducing computational time becomes a priority when analyzing 
large volumes of data. Recently reported pipelines primarily 
use traditional local alignment tools like BLAST/BLAT (Altschul 
et  al., 1990; Kent, 2002) for at least one step of the NGS 
clonality workflow. These tools perform poorly in protocols 
that typically require the alignment of several million short 
sequences (Paruzynski et al., 2010; Firouzi et al., 2014; Maldarelli 
et  al., 2014; Cohn et  al., 2015; Aoki et  al., 2016; Farmanbar 
et al., 2017). We applied the short-read aligner bowtie (Langmead 
et  al., 2009) or bowtie2 (Langmead and Steven, 2013) at every 
step of the protocol to a set of reads from our HTLV-1 and 
BLV clonality datasets (Figure  2, steps 1–2–4, see Materials 
and Methods section) and demonstrated that this dramatically 
reduced both processing time and memory footprint (Figure 3). 
In addition, short-read aligners consider base quality, significantly 
increasing alignment specificity.
Trimming Short Reads to Improve 
Alignment
We observed that mapping of raw reads to the host genome 
resulted in a significant number of misaligned bases at the 
read extremities (soft-clipped sequences). The presence of 
mismatches increases the level of uncertainty in the alignment, 
which is reflected in the mapping quality score (MAPQ). Reads 
with a low MAPQ have a greater chance of being filtered out 
to avoid retaining misalignments. The majority of these 
mismatches result from the presence of sequencing adapters 
and viral sequences, which can be  eliminated from reads prior 
to mapping them to a reference genome (Figure 4A). We used 
fastx_trimmer to remove adapters and proviral LTR sequences 
based on their respective theoretical length (Figure  2, step  3).3 
3 http://hannonlab.cshl.edu/fastx_toolkit/
FIGURE 2 | Workflow diagram. Sequencing of clonality libraries produces pairs of 150-bp reads. Read 1 (R1) contains a complexity sequence, a partial LTR 
sequence from the LTR primer to the LTR extremity (LTR), and the flanking host genomic sequence defining the integration site. Read 2 (R2) contains a random tag, 
the linker sequence, and the host genomic sequence defining the shear site. Read pairs originate from either the 5'LTR or the 3'LTR (shown here is the 3'LTR 
configuration). The pipeline identifies the integration site, shear site, and random tag of each pair of reads (see Materials and Methods section). Reads sharing the 
same integration site are grouped and, the abundance of the corresponding clone is computed after removal of PCR duplicates.
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In the majority of these cases, we observed a strong bias toward 
reads with short insert sizes (=distance between R1-start and 
R2-end alignment) characterized by frequent overlaps between 
reads R1 and R2 of the same pair (mean: 28.06%; Figure  4B). 
More specifically, we  found that the sequence of one read of 
the pair frequently overlapped a region of its mate read, 
creating soft-clipped bases at the extremity of the fragment 
despite appropriate trimming of adapter and LTR sequences. 
A B E
C D
FIGURE 3 | Improving read mapping processing speed. Reads from BLV (A,B) or HTLV-1 (C,D) clonality libraries containing 3'LTR-specific sequences were 
identified using either bowtie2 (-L 14 -N 1 -U; blue) or BLAST (red) with variable thread numbers (line types). RAM usage (A,C) and speed (B,D) were examined. The 
proportion of reads containing the appropriate 3'LTR sequence was compared between the two procedures (E).
A
B
FIGURE 4 | Trimming sequencing reads increases the number of reads supporting the proviral integration sites. (A) Schematic representation of sequenced DNA 
fragments. The DNA “insert size” is measured from the start to the end of the mapped portion of the DNA fragment, which corresponds to the host genomic 
sequence. R1 reads generated from small DNA inserts carry sequences corresponding to the linker of R2 at their extremity, while their R2 counterparts can contain 
a fraction of the LTR sequence found in R1 (residual sequences). (B) Distribution of insert sizes across mapped reads from HTLV-1 (human) and BLV (ovine) clonality 
libraries (mean represented in blue). Reads produced from short fragments affected by sequence overlap are shown by pink area. Overlap R2 (red dashed line), 
overlap both reads (blue dashed line). Boxplots: percentage of reads in each category. Barplots: percentage of reads mapping to the host genome prior to (green) 
and after (orange) trimming. 5' LTR data: left, 3' LTR data: right.
Rosewick et al. Improved Bioinformatics Pipeline NGS Clonality
Frontiers in Microbiology | www.frontiersin.org 7 October 2020 | Volume 11 | Article 587306
The application of cutadapt (Martin, 2011) to remove the 
corresponding overlapping sequences significantly increased the 
number of uniquely mapped reads (up to 30%), resulting in 
a higher number of reads supporting the proviral integration 
site (Figure  4B). Bias toward small insert size is influenced 
by the fragment length distribution after ultrasonic shearing, 
PCR amplification, bead selection of amplified sequences, and 
library sequencing. The magnitude/severity of this bias may 
therefore vary among protocols.
Adjusting the Accuracy of Clone 
Abundance Quantification for Integration 
Sites Located Within Repetitive Regions of 
the Host Genome
Low-complexity sequences are frequent in eukaryotic genomes, 
and regions that contain such repetitive elements are difficult 
to resolve with short reads. Integration sites falling within 
low-complexity regions will often be  attributed inaccurate 
clone abundances due to the poor mapping quality of 
sequencing reads supporting these sites. A representative 
example is ATL 2, a primary ATL classified as an acute 
leukemia subtype, which consists of a single dominant T-cell 
clone as revealed by the presence of a clonal T-cell receptor 
gamma gene rearrangement (Rosewick et  al., 2017). 
Surprisingly, NGS mapping of proviral integration sites of 
ATL 2 revealed two major HTLV-1 insertions in chr5 and 
chr16 with a relative abundance of 49.5 and 36.3%, respectively, 
and a third minor integration site in chr1 representing 13.6% 
(Figure  5A). In contrast, the application of PCIP-seq, an 
Oxford Nanopore-based long-read sequencing method 
developed by us to capture proviral integration sites and 
simultaneously sequence the viral genome associated with 
each site (Artesi et al., 2019), revealed three major proviruses 
located on chr5, chr16, and chr1  in ATL 2, each responsible 
for 33.7, 34.5, and 31.8% of the HTLV-1/host hybrid reads, 
respectively. These data suggested the presence of three 
proviral integrations in a single T-cell clone. We  observed 
that the proviral insertion site on chr1 falls within a repetitive 
element causing many of the short reads to map to multiple 
regions in the genome. As a result, most of the reads obtained 
with our short-read NGS clonality method had been discarded 
due to poor alignment quality (MAPQ  <  30). In contrast 
to the long reads from PCIP-seq, which allow unambiguous 
mapping in repetitive regions, we  observed that in our 
Illumina-based method, retaining multimapped reads produced 
values closer to reality (25.4%, Figure  5A, after recall). 
Therefore, to correct for the abundance of this integration 
site, we  applied a two-pass “recall” step in our workflow. 
Integration sites were first defined according to the reads 
in proper pair (=SAM flag 0x2) with a high MAPQ  >  30. 
Proper-pair reads are defined as mapped in pairs, in the 
expected relative orientation and within a distance compatible 
with the aligner’s parameters. In a second step, reads with 
lower mapping quality were recovered. For each integration 
site identified, we  then recomputed the number of reads 
associated with that particular site using reads with lower 
mapping quality aligning to multiple positions located within 
a window spanning 600  bp up‐ and downstream of the 
integration site initially defined by the high MAPQ reads. 
Multimapped reads that matched several high confidence 
integration sites were preferentially attributed to the integration 
site with the highest abundance. Altogether, our findings 
suggest that applying an extra recall step in the clonality 
bioinformatics workflow results in a more accurate estimation 
of clone abundance for proviral integration sites localized 
in low-complexity repetitive regions of the genome. Applied 
to the entire NGS clonality dataset, the recall method did 
not dramatically affect the abundance of the majority of 
the clones (Figure  5B, cor  =  0.9885588, n  =  45,739).
Cleaning Datasets and Recovering 
Integration Sites
We applied our high-throughput protocol to several hundred 
samples collected from HTLV-1‐ and BLV-infected individuals 
and after processing, the data obtained 35,758 and 302,740 
unique proviral integration sites, respectively. This revealed 
A B
FIGURE 5 | Applying a recall step improves accuracy of estimating clone abundance. (A) Pie charts representing proviral integration site distribution of ATL 2 
generated with the conventional pipeline (left chart) or the recall procedure (right chart). Each slice of a pie represents an independent proviral integration site, and 
the size of the slice corresponds to the relative abundance (percentage in HTLV-1-infected cells). (B) Impact of the recall procedure on the clonality dataset (see 
Materials and Methods section) for integration sites supported by >15 reads. ATL_2-1 and ATL_2-2: two independent samplings of ATL 2.
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recurrent integration sites across samples likely caused by 
incorrectly assigned reads as the chance of finding an identical 
insertion site in two independent individuals is extremely low. 
Possible causes are cross-contamination during library 
preparation, bioinformatics issues in the demultiplexing process 
or index hopping and carryover during or between sequencing 
runs, which have been described as the main source of 
misassignment when sample and library preparation are processed 
in rigorously controlled conditions. Addressing this concern 
is particularly critical in longitudinal studies, which basically 
aim at examining a cohort of infected individuals (HTLV-1 
or BLV in our studies) as well as multiple serial samples from 
the same individual. Cross-contamination will result in the 
inaccurate identification of identical integration sites across 
distinct samples.
To identify the sample to which the recurrent integration 
site should be  assigned, we  considered two parameters. First, 
the maximum number of reads associated with this particular 
integration site across all individuals and all samples 
(Sa, “abundance”). Second, the maximum number of occurrences 
of this given integration site in each individual (Sr, “recurrence”). 
For both parameters, we  compute the Shannon entropy 
(Shannon, 1948), which recapitulates how skewed the presence 
is of an integration site in a given individual. Low Shannon 
entropy values indicate more diversity, with values close to 
zero representing the most dissimilar distributions. A schematic 
representation of the method is shown in Figure  6. Using 
empirical thresholds (here Sa or Sr <0.85), we  assign each 
integration site to one of the following classes: abundance, 
occurrence, or uncertain. The “abundance” and “occurrence” 
categories define integration sites that can be  attributed to 
a specific individual based on a higher proportion of reads 
identified in one individual (Figure  6, Case 1) or a greater 
recurrence of this insertion site in serial samplings collected 
from this individual (Figure  6, Case 2). Integration sites 
belonging to these categories will be  assigned to a single 
individual and recovered. The third class defines integration 
sites that cannot be  attributed to a unique individual with 
sufficient confidence (Figure  6, Case 3). IS classified as 
uncertain will be  eliminated. Applied to our ovine BLV IS 
dataset (704,485 total IS, 377,710 unique IS prior to final 
merging), this approach resulted in the recovery of 23.75% 
(2,121 IS) of all recurrent integration sites (8,914 IS). This 
protocol appeared particularly useful for integration sites 
corresponding to abundant predominant clones, which are 
more likely to contaminate other samples.
FIGURE 6 | Cleaning clonality datasets and recovering integration sites. Schematic representation of the pipeline designed to address cross-contamination and 
carryover. The method is based on the assumption that analyzing the clone distribution among all time-points (i.e., T1–T5) and individuals (i.e., I1, I2) can 
discriminate real integration sites from cross-contamination/carryover. According to information on clone abundance and number of occurrences of a specific 
integration site in each individual, we define three categories. Case 1: the highest clone abundance across all samples is found in one individual (I1). Case 2: the 
integration site is recurrently found in a single individual (I1). Case 3: all individuals show similar clone abundances and integration site occurrences. Skewness in 
clone abundance and occurrence distributions is assessed by computing the Shannon entropy (Sa or Sr). In Cases 1 and 2, the integration site is assigned to 
individual I1 and removed from individual I2’s integration site list. Integration sites that do not fulfill these criteria are flagged as uncertain and eliminated (Case 3).
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DISCUSSION
The application of ligation-mediated PCR protocols combined 
with NGS is having a large impact on our understanding 
of retroviral pathogenesis. Recently, considerable effort has 
been expended to optimize NGS clonality methods and 
explore the clonal architecture of clinically important 
retroviruses like HTLV-1 and HIV-1. Once sequencing data 
are generated, the application of rigorous bioinformatics 
analysis is central to the biological interpretation of the 
data. To better exploit the potential of these methods, 
we  developed an optimized bioinformatics pipeline for 
analyzing NGS clonality datasets. Here, we  report a detailed 
workflow and describe a set of improved or additional steps 
in the computational protocol. We demonstrate that application 
of these steps to HTLV-1 and BLV clonality datasets provides 
a better estimation of proviral integration site distribution 
and a more accurate picture of the clonal landscape in 
infected individuals.
With the development of cost-effective NGS clonality 
methods and the availability of NGS platforms for routine 
diagnosis applications, there is increasing interest from the 
clinical community to monitor the clonal architecture of 
HTLV-1-infected ATL patients. Given the urgent need for 
novel therapeutic strategies for this poorly controlled T-cell 
malignancy, patients with aggressive and refractory forms of 
ATL will be  increasingly enrolled in clinical trials requiring 
systematic monitoring of therapeutic responses. In addition 
to managing ATL patients, routine NGS clonality analysis of 
asymptomatic HTLV-1-infected individuals has the potential 
to identify carriers at greater risk of developing ATL. Such 
routine clinical applications require highly accurate measures 
of clone abundance. A short processing time for NGS data 
is a priority when answering questions regarding clinical 
outcomes for HTLV-1-infected patients. With the generation 
of massive volumes of sequencing data in the context of 
experimental studies, processing speed has also gained 
increasing importance in basic research. Here, we demonstrate 
that in contrast to BLAST/BLAT, short-read aligners specifically 
designed to manage NGS datasets offer increased speed, 
reducing processing times by an order of magnitude while 
accounting for sequencing base quality. In addition, short-
aligner usage also lessens the computational burden that 
accompanies this step.
Both BLAST and most short-read aligners depend on seed-
and-extend strategies (Li and Homer, 2010). If a sufficient 
match (or seed) between the sequencing read and the indexed 
reference genome is found, the alignment algorithm will attempt 
to extend it, assigning a different weight to a perfect match, 
a deletion, or a mismatch. Keeping mismatches or soft-clipped 
sequence stretches, which may stem from adapters or “residual” 
sequences from library preparation, critically impacts the 
alignment accuracy and the global output. We  recommend a 
step to perfectly clean all sequencing reads from nongenomic 
contaminating sequences before mapping to the reference 
genome. Tools like cutadapt or fastx_trimmer have been 
developed to trim NGS reads, eliminating adapter and undesired 
sequences while also taking into consideration sequence quality. 
Our results demonstrate the utility of this additional cleaning 
step for adjusting the number of reads supporting an insertion 
site, providing a more accurate estimation of clone abundance.
To improve the accuracy of insertion site identification in 
repetitive regions of the host genome, we  developed a recall 
procedure. Filtering low-quality NGS reads is highly 
recommended to avoid false positives; however, applied to 
low-complexity genomic regions, quality filters will impair 
the detection of proviral integration sites, inflating the 
abundance of integration sites assigned to higher-complexity 
genomic regions. We  demonstrate that reads aligning to 
multiple regions in the genome can be  used with a certain 
degree of confidence when a fraction of them map uniquely 
to that region. We  further demonstrated that the recall 
procedure improved the accuracy of clone abundance estimates 
for HTLV-1 integration sites in repetitive regions of the human 
genome, enabling restoration of the clonal landscape in complex 
HTLV-1 samples.
Finally, we  recommend the application of a “clean-and-
recover” step especially for datasets generated from large cohorts 
and longitudinal studies. Applying this additional step to our 
dataset recovered about one fourth of the recurrent integration 
sites, which would otherwise have been eliminated. This set 
included integration sites corresponding to biologically important 
clones such as predominant malignant clones and their precursors. 
A major limitation of this approach is its dependence on 
empirical thresholds to discriminate between insertion sites 
that can be  eliminated and those that should be  retained. 
Integration sites supported by repeated occurrence within an 
individual and/or high abundance can be  assigned with 
confidence and recovered; however, other contaminating 
integration sites should be assessed with caution and discarded.
CONCLUSION
We further optimized the bioinformatics pipeline and describe 
critical steps in the computational processing protocol for 
NGS clonality datasets generated from HTLV-1 and BLV-infected 
individuals. We  demonstrate that the application of rigorous 
steps in the bioinformatics process is critical to address some 
of the biases associated with the nature of LAM-PCR-based 
sequencing libraries. The application of our optimized 
bioinformatics protocol to HTLV-1 and BLV NGS clonality 
datasets decreases total execution time and reduces the 
bioinformatics burden while taking into account read quality. 
The workflow significantly improves the accuracy of estimating 
clone abundance by reducing biases associated with the presence 
of residual sequences and proviral integration within 
low-complexity regions of the genome. This updated workflow 
is applicable to the majority of bioinformatics pipelines 
developed to analyze NGS clonality datasets, requiring minimal 
adjustments. In addition to its application in research, it will 
be  particularly useful for analyzing NGS clonality data from 
HTLV-1 patients when tracking risk to progression, disease 
evolution, and response to therapy.
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